tradingkey.logo

Cosmos Health Inc

COSM
0.450USD
+0.010+2.23%
Handelsschluss 02/06, 16:00ETKurse um 15 Minuten verzögert
14.33MMarktkapitalisierung
VerlustKGV TTM

Cosmos Health Inc

0.450
+0.010+2.23%

mehr Informationen über Cosmos Health Inc Unternehmen

Cosmos Health Inc. is a diversified, vertically integrated global healthcare company. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe, C-Sept and C-Scrub. Through its subsidiary Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. It also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and over-the-counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. It also has research and development (R&D) partnerships targeting health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of patented nutraceuticals, specialized root extracts, proprietary complex generics, and OTC products.

Cosmos Health Inc Informationen

BörsenkürzelCOSM
Name des UnternehmensCosmos Health Inc
IPO-datumMay 19, 2010
CEOSiokas (Grigorios)
Anzahl der mitarbeiter149
WertpapierartOrdinary Share
GeschäftsjahresendeMay 19
Addresse5 Agiou Georgiou, Pilea
StadtTHESSALONIKI
BörseNASDAQ OMX - NASDAQ BASIC
LandGreece
Postleitzahl554 38
Telefon303125363102
Websitehttps://www.cosmosholdingsinc.com/
BörsenkürzelCOSM
IPO-datumMay 19, 2010
CEOSiokas (Grigorios)

Führungskräfte von Cosmos Health Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Grigorios Siokas
Mr. Grigorios Siokas
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
8.18M
+1465349.00%
Mr. Georgios (George) Terzis
Mr. Georgios (George) Terzis
Chief Financial Officer
Chief Financial Officer
727.26K
--
Dr. Anastasios (Tasos) Aslidis
Dr. Anastasios (Tasos) Aslidis
Independent Director
Independent Director
40.00K
--
Mr. Suhel Bhutawala
Mr. Suhel Bhutawala
Independent Director
Independent Director
30.00K
--
Mr. Demetrios G. Demetriades
Mr. Demetrios G. Demetriades
Independent Director
Independent Director
20.00K
--
Mr. John James Hoidas
Mr. John James Hoidas
Independent Director
Independent Director
15.00K
--
Mr. Nikos Bardakis
Mr. Nikos Bardakis
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Theodoros C. Karkantzos
Mr. Theodoros C. Karkantzos
Director
Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Grigorios Siokas
Mr. Grigorios Siokas
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
8.18M
+1465349.00%
Mr. Georgios (George) Terzis
Mr. Georgios (George) Terzis
Chief Financial Officer
Chief Financial Officer
727.26K
--
Dr. Anastasios (Tasos) Aslidis
Dr. Anastasios (Tasos) Aslidis
Independent Director
Independent Director
40.00K
--
Mr. Suhel Bhutawala
Mr. Suhel Bhutawala
Independent Director
Independent Director
30.00K
--
Mr. Demetrios G. Demetriades
Mr. Demetrios G. Demetriades
Independent Director
Independent Director
20.00K
--
Mr. John James Hoidas
Mr. John James Hoidas
Independent Director
Independent Director
15.00K
--

Umsatzaufteilung

Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach RegionUSD
Name
Umsatz
Anteil
Greece
16.39M
95.77%
UK
512.54K
3.00%
United Arab Emirates (
118.40K
0.69%
Cyprus
56.93K
0.33%
Albania
23.41K
0.14%
Andere
11.89K
0.07%
Nach Geschäftsbereich
Nach Region
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.

Aktionärsstatistik

Aktualisiert: Fri, Jan 2
Aktualisiert: Fri, Jan 2
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Siokas (Grigorios)
23.43%
Bovopoulos (Andreas D)
4.16%
Terzis (Georgios)
2.08%
BlackRock Institutional Trust Company, N.A.
0.77%
The Vanguard Group, Inc.
0.68%
Andere
68.88%
Aktionäre
Aktionäre
Anteil
Siokas (Grigorios)
23.43%
Bovopoulos (Andreas D)
4.16%
Terzis (Georgios)
2.08%
BlackRock Institutional Trust Company, N.A.
0.77%
The Vanguard Group, Inc.
0.68%
Andere
68.88%
Aktionärstypen
Aktionäre
Anteil
Individual Investor
30.10%
Investment Advisor
1.56%
Hedge Fund
0.91%
Investment Advisor/Hedge Fund
0.70%
Venture Capital
0.19%
Research Firm
0.12%
Bank and Trust
0.02%
Andere
66.40%

Institutionelle Beteiligung

Aktualisiert: Mon, Dec 8
Aktualisiert: Mon, Dec 8
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
39
1.21M
8.69%
--
2025Q3
40
1.21M
10.09%
+200.56K
2025Q2
40
1.01M
10.29%
-1.71M
2025Q1
38
2.72M
7.86%
+891.30K
2024Q4
38
1.62M
11.55%
-779.82K
2024Q3
39
2.40M
4.16%
+1.81M
2024Q2
40
591.35K
13.72%
-13.70K
2024Q1
40
605.05K
14.49%
-1.85M
2023Q4
39
1.97M
8.60%
+1.22M
2023Q3
36
746.56K
8.56%
-123.02K
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Siokas (Grigorios)
6.72M
19.23%
+256.79K
+3.98%
Dec 19, 2025
Bovopoulos (Andreas D)
1.45M
4.16%
-427.73K
-22.74%
Aug 13, 2025
Terzis (Georgios)
727.26K
2.08%
--
--
Aug 01, 2025
BlackRock Institutional Trust Company, N.A.
267.80K
0.77%
--
--
Sep 30, 2025
The Vanguard Group, Inc.
235.74K
0.68%
+100.91K
+74.84%
Sep 30, 2025
Citadel Advisors LLC
225.51K
0.65%
+128.78K
+133.13%
Sep 30, 2025
Geode Capital Management, L.L.C.
198.68K
0.57%
+7.12K
+3.72%
Sep 30, 2025
Renaissance Technologies LLC
92.80K
0.27%
+92.80K
--
Sep 30, 2025
XTX Markets LLC
65.49K
0.19%
+28.79K
+78.45%
Sep 30, 2025
Bardakis (Nikolaos)
45.00K
0.13%
--
--
Aug 01, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
Anteil0%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Dec 15, 2022
Merger
25→1
Dec 15, 2022
Merger
25→1
Dec 15, 2022
Merger
25→1
Dec 15, 2022
Merger
25→1
Datum
Ex-Dividendentag
Art
Verhältnis
Dec 15, 2022
Merger
25→1
Dec 15, 2022
Merger
25→1
Dec 15, 2022
Merger
25→1
Dec 15, 2022
Merger
25→1
KeyAI